SLC2A1 variants are associated with late-onset mild epilepsy, which is consistent with the genetic-dependent stage of SLC2A1. Early genetic diagnosis implies the significance of treatment in patients with SLC2A1 variants. Here, SLC2A1 is linked to epilepsy.